Expert says Super Bowl unlikely to spread tuberculosis after KC outbreak
News of a centered in Wyandotte and comes as likely tens of thousands of fans from the region are about to head to the Super Bowl which will be played indoors at New Orleans Caesars Superdome.
Countless more fans will attend Super Bowl parties around the area.
However, medical professionals say there's little reason to be concerned the Super Bowl will be a super spreader. It really comes down to how contagious tuberculosis is compared to other respiratory illnesses and where we seem to be on the outbreak's timeline.
Flu map: These states are now at CDC's highest activity level
Five years ago the Kansas City Chiefs won their first Super Bowl in 50 years and by some accounts may have slowed the spread of COVID-19.
There's debate whether fans who attended the game a month before nationwide shut downs may have already been infected. But many of the earliest confirmed cases during that timeframe were in California.
Instead of celebration in San Francisco, it was in Kansas City where hundreds of thousands crammed in to areas around Union Station for a Super Bowl parade and rally.
Now it's the Kansas City metro, . FOX4 sat down with University of Kansas Hospital Infection Control and Prevention Medical Director Dr. Dana Hawkinson to find out if the game and celebrations pose a risk.
'Things like influenza, SARS-CoV-2 and those common cough and cold viruses they are still at fairly high levels in the United States. You are at significantly more at risk of getting one of those infections than you are tuberculosis,' Hawkinson said.
Provisional numbers say 630 Kansans had latent tuberculosis in 2024, but those are people who don't have symptoms and can't spread it until the disease becomes active without treatment. KDHE data shows the biggest spike of latent cases was in March of last year, while new active cases spiked in June.
Seven cases were listed as active on January 24 in Johnson County. Wednesday Johnson County said all its tuberculosis patients receiving treatment were no longer infectious. At last update, Wyandotte County had 60 active cases.
If you are lucky enough to get Super Bowl tickets or have party plans and develop a cough, Hawkinson says it's no reason to immediately cancel. As always do your best to help reduce the spread of viruses by covering your cough, practicing proper hand hygiene and making sure you are fever-free. But if you truly have active tuberculosis your body has probably already been telling you.
'Those symptoms are prolonged things like cough and bloody cough, which is called hemoptysis, fevers and night sweats. These persist for several weeks to months. So I think that's distinctly different from someone who has cold and cough that may persist for 10 days,' Hawkinson said.
See the latest headlines in Kansas City and across Kansas, Missouri
University of Kansas Hospital has been working with KDHE on contact tracing for months. That's a key way latent cases are discovered.
According to medical professionals, tuberculosis differs greatly from COVID-19, cold or flu as it takes prolonged exposure to someone with active disease to get it, likely not someone coughing next to you, even if it is for a few hours.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
29 minutes ago
- The Hill
CDC finalizes roughly 600 layoffs
The cuts are across the agency, including the Division of Violence Prevention, equal employment opportunity, open records law compliance, the Office of Financial Resources, the offices of the chief information and chief operating officers, and more, according to union officials. The cuts were expected after U.S. District Judge Melissa R. DuBose, a Biden appointee, scaled back the scope of an initial ruling finding broad layoffs unlawful. DuBose specified that certain subagencies and programs were blocked off from layoffs, including the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention; the Division of Reproductive Health; and the National Institute for Occupational Safety and Health. This left unnamed subagencies open to layoffs. An HHS spokesperson confirmed the layoffs when contacted by The Hill, noting the staff reductions are the final piece of the process that began in March as part of President Trump's Department of Government Efficiency executive order. The AFGE blasted the timing of the firings, taking place so soon after the fatal shooting that occurred at the CDC's offices in Atlanta. 'HHS [Department of Health and Human Services] has shown that it does not have the organizational or operational capacity to take over the support functions that the agency had before these firings. This reduction in force was operationally a mess. They have shown they are in no way prepared to support CDC when America needs it most,' the union said in a statement. The firings add to the anger among HHS employees, who say Secretary Robert F. Kennedy Jr. has undermined their work with his rhetoric against vaccines and public health workers. More than 750 current and former employees sent Kennedy a letter on Wednesday calling on him to stop 'spreading inaccurate health information' and do more to protect public health professionals in the wake of the shooting.
CBS News
39 minutes ago
- CBS News
Are you aware if the food you're eating is ultra-processed? The answer could make all the difference for your health
An alarming look at the foods consumed by families across America: A recent study from the Centers for Disease Control and Prevention (CDC) reveals that most Americans get more than half of their daily calories from ultra-processed foods, and that's leading to some serious health issues. CBS News Miami visited a South Florida family's kitchen with a nutritionist to gather information that can help you live a better life. Katrina and Charles Winters spend a lot of time in their kitchen. They homeschool their daughter, preparing all her daily meals and run a meal service for their employees. "Most of our food is pretty natural, whole food," said Katrina Winters. "I would say that we do have a snack cabinet that we keep pretty stocked for our daughter, also, I take her to school and I need to have things I can just grab and go in the car." "I travel a lot, so we do have to eat out quite a lot but when we are home we are cooking a most of our meals here," added Charles Winters. Founder of Essence Nutrition, dietitian Monica Auslander-Moreno, examined their pantry and refrigerator to highlight what they're doing well and areas for improvement. "This is a processed food; there is nothing that has been added to these hazel nuts, so that's great, but someone had to put them in this bag and that's okay," said Auslander-Moreno. "These are peanut butter and jelly dippers; this would be an ultra-processed food. It doesn't necessarily mean that I wouldn't eat them, but we would define them as a UPF," she continued. Ultra-processed foods (UPFs) are typically low in fiber and high in salt, sweeteners and unhealthy fats. The most common offenders include burgers, sandwiches, sweet baked goods, savory snacks, pizza and sweetened beverages. "The concern is that we are displacing the whole foods, the fruits and vegetables. Or the lightly processed foods, like the lightly frozen fruits and vegetables, and we are going to suffer from completely preventable diseases as a result of consuming these ultra-processed foods," Auslander-Moreno said. Studies have associated these types of foods with obesity, type 2 diabetes and heart disease. According to the new CDC report, from August 2021 to August 2023, individuals aged one year and older consumed an average of 55% of their total calories from ultra-processed foods. Children aged 1-18 consumed an even higher percentage, at 61.9%, compared to adults 19 and older, who averaged 53% CBS News Miami's nutrition expert emphasized that children often emulate their parents' behavior, as displayed by 5-year-old Jaco and his little brother, who can easily list their favorite healthy foods. "Cucumbers, avocados, and hearts of palm and chicken," Jaco exclaimed. "Hahah yeah, chicken." Auslander-Moreno told CBS News Miami that she asks people two questions to help them determine whether they're eating an ultra-processed food. "Two rules, so I ask people if their great, great, great grandmother or grandfather would recognize this food as indeed being food and if they could define that for you," she said. "[And] I would ask them if I give them all the food categories based on the MyPlate recommendations, 'Where would you put this food? Is it a fruit, is it a vegetable, how would you categorize it?' and then lastly, tell me where this food grew in the earth, or walked on the earth or swam in the ocean, and if those are really challenging questions to answer, it's likely a UPF." Auslander-Moreno shared her suggestions on how to replace common ultra-processed foods in your diet: Instead of hamburgers with frozen beef patties: Consider a salmon burger, cook it with olive oil and add lots of vegetables. Instead of sodas, opt for: Sparkling waters. You can also muddle cucumbers and citrus infuse them into sparkling or plain water. And instead of baked goods: Try baked apples with cinnamon. While technically baked, it's simply fruit with spice and satisfies that pie craving. You can top it with nuts or plain Greek yogurt. Experts also said to be cautious of products that seem healthy based solely on their packaging. Learn to read labels closely, and if you see an ingredient you don't recognize, research it to understand what you're consuming.
Business Wire
an hour ago
- Business Wire
AAHI Partners with Quratis to Strengthen Global Vaccine Manufacturing and Accelerate Access to Lifesaving Vaccines
SEATTLE--(BUSINESS WIRE)--Access to Advanced Health Institute (AAHI), a global leader in translating high-impact science into scalable, field-ready vaccine solutions, today announced an exciting new partnership with Quratis, a premier biotechnology company and advanced Contract Development and Manufacturing Organization (CDMO). This collaboration marks a pivotal step forward in breaking through barriers in global health equity around the world. Under this strategic alliance, Quratis has been selected as AAHI's preferred manufacturer for high-quality pre-clinical and clinical vaccine supplies, with the capacity to expand into commercial-scale production for global markets. This collaboration will accelerate the development of AAHI's innovative vaccine candidates targeting deadly diseases such as tuberculosis, and of vaccines that rely on AAHI's vaccine adjuvants to provide protection against malaria, HIV, and other global health threats. Quratis brings a world-class GMP-certified bioplant and cutting-edge CDMO expertise in biopharmaceutical raw material development, process optimization, and finished pharmaceutical manufacturing. By designating Quratis as preferred partner, AAHI strengthens both its scientific capabilities and access to scalable, cost-effective production of its groundbreaking vaccine formulations—including dry vaccines that eliminate cold chain dependencies and needle-free delivery systems for superior respiratory protection. The partnership ensures a seamless supply chain platform, enabling swift clinical development and broader deployment to the world's most vulnerable populations. "Partnering with Quratis is a very important step in AAHI's strategy to advance practical, life-saving vaccines, that can be deployed at scale where they're needed most,' said Keeley Foley, CEO of AAHI. 'Quartis' innovative cutting edge, safe, world-class CDMO capabilities makes it possible for AAHI to deliver on our mission – and helps ensure our efforts to combat infectious diseases and foster health autonomy worldwide. Together, we're not just manufacturing vaccines—we're delivering an important mission to revolutionize global health." Quratis, renowned for its global innovation in healthcare, brings unparalleled expertise in vaccine development and manufacturing to the table. With a track record of success in TB and COVID-19 vaccines like QTP101 and QTP104, Quratis' advanced processes will enhance AAHI's pipeline, ensuring high-quality, efficient production from pre-clinical stages through clinical trials. "We are honored and thrilled to join forces with AAHI, a pioneer in immune-enhancing technologies and sustainable vaccine solutions," said Soung Joon Kim, CEO of Quratis. "This partnership aligns perfectly with our vision of making people happy and healthy through borderless healthcare innovations. By supporting AAHI's pipeline, we expect to create value not only for global health, but also for our shareholders through long-term growth opportunities.' The partnership builds on existing collaborations, including the co-development of the ID93+GLA-SE tuberculosis vaccine candidate (QTP101), and underscores a shared commitment to strengthening international vaccine supply chains, advancing equitable access, and fostering worldwide manufacturing capacity for sustainable program deployment. For more information about this partnership or to explore collaboration opportunities, and order pre clinical materials please contact info@ About Access to Advanced Health Institute (AAHI) Access to Advanced Health Institute (AAHI) is a global leader in developing practical, cost-effective vaccines to combat deadly diseases such as tuberculosis, malaria, and HIV. With a mission to translate high-impact science into scalable, field-ready solutions, AAHI breaks through barriers in global health by creating innovative vaccine formulations, building worldwide manufacturing capacity, and fostering partnerships to ensure sustainable, equitable health outcomes. For more information, visit or contact us at info@ About Quratis Quratis Inc. is a leading biopharmaceutical company specializing in innovative vaccine development and advanced biologics manufacturing. With a state-of-the-art GMP facility and strong global partnerships, Quratis is at the forefront of developing next-generation vaccines against infectious diseases, including tuberculosis, COVID-19, schistosomiasis, and neglected tropical diseases. In addition to its core vaccine pipeline, Quratis offers superior CDMO capabilities, including expertise in mRNA–LNP drug delivery platforms that provide seamless bench-to-field support from research through commercial production. By combining cutting-edge R&D with scalable manufacturing, Quratis is committed to delivering high-quality, accessible, and life-saving solutions to patients worldwide. For more information, visit
